Diagnosis and treatment

A pedestrian walks across the street from a McKesson sign on an office building in San Francisco, Wednesday, July 17, 2019. Newly released federal data shows how drugmakers and distributors increased shipments of opioid painkillers across the U.S. as the nation’s addiction crisis accelerated from 2006 to 2012. McKesson distributed more than 18% of the nation's opioids from 2006 to 2012 — the most of any company — but said it didn't push sales. (AP Photo/Jeff Chiu)
July 17, 2019 - 7:26 pm
WASHINGTON (AP) — The maker of OxyContin has been cast as the chief villain in the nation's opioid crisis. But newly released government figures suggest Purdue Pharma had plenty of help in flooding the U.S. with billions of pills even as overdose deaths were accelerating. Records kept by the...
Read More
July 16, 2019 - 1:55 pm
CLEVELAND (AP) — A look at how the opioid crisis grew and spread may be much clearer soon after a federal judge overseeing nearly 2,000 lawsuits filed against manufacturers, distributors and retailers of prescription painkillers ordered the release of data showing where those drugs were distributed...
Read More
FILE- This Nov. 14, 2018, file photo shows Lubriderm, a Johnson & Johnson product, on display at a market in Pittsburgh. Johnson & Johnson reports financial results on Tuesday, July 16. (AP Photo/Gene J. Puskar, File)
July 16, 2019 - 8:18 am
Johnson & Johnson posted slightly lower sales across much of its business in the second quarter, but a big one-time gain and lower spending on marketing and administration boosted its profit a whopping 42 percent. That blew past Wall Street expectations. The maker of baby shampoo and cancer and...
Read More
In this July 9, 2019 photo, Dr. Jori Fleisher, neurologist, examines Thomas Doyle, 66, at the Rush University Medical Center in Chicago. Doyle, 66, hopes blood tests may someday replace the invasive diagnostic testing he endured to be diagnosed 4.5 years ago with Lewy body dementia. (AP Photo/Teresa Crawford)
July 15, 2019 - 4:02 pm
LOS ANGELES (AP) — Scientists are closing in on a long-sought goal — a blood test to screen people for possible signs of Alzheimer's disease and other forms of dementia. On Monday at the Alzheimer's Association International Conference, half a dozen research groups gave new results on various...
Read More
In this Tuesday, July 2, 2019 photo, Darren Johnson, a hemp processor, holds raw hemp that will be used to make CBD oil at his processing facility, Wasatch Extraction, in Salt Lake City. Johnson is one of 81 applicants vying for a medical marijuana growers license in Utah. (AP Photo/Morgan Smith)
July 12, 2019 - 1:28 am
NEPHI, Utah (AP) — The wide metal barn on the Utah alfalfa farm owned by Russell and Diane Jones will host their youngest son's wedding next month. By September, they hope the structure will be full of marijuana plants. The Joneses are fourth-generation farmers, members of The Church of Jesus...
Read More
In this 2014 photo provided by the University of Mississippi, Dr. Suman Chandra inspects marijuana plants growing at the Ole Miss medicinal gardens in University, Miss. The plants are used for research under a contract from the National Institute on Drug Abuse. The planned NIDA grow for 2019 will be divided between high THC and high CBD varieties with “recent interest (in CBD) as a potential medicine for a number of medical conditions,” NIDA said. (Robert Jordan/University of Mississippi via AP)
July 11, 2019 - 6:53 pm
The U.S. government is growing the largest crop of research marijuana in five years, responding to interest in varieties with high levels of THC and CBD. The government is the only source of pot for nearly all research, while it still considers it illegal and dangerous. The National Institute on...
Read More
President Donald Trump speaks about kidney health at the Ronald Reagan Building and International Trade Center, accompanied by Health and Human Services Secretary Alex Azar, left, Wednesday, July 10, 2019, in Washington. (AP Photo/Alex Brandon)
July 11, 2019 - 6:08 pm
WASHINGTON (AP) — After two setbacks this week, President Donald Trump is now focusing his drive to curb drug costs on congressional efforts aimed at helping people on Medicare and younger generations covered by workplace plans. The White House on Thursday yanked its own regulation to ease the...
Read More
President Donald Trump kisses Hudson Nash, being held by father Andrew Nash, as Trump speaks about kidney health at the Ronald Reagan Building and International Trade Center, Wednesday, July 10, 2019, in Washington. (AP Photo/Alex Brandon)
July 10, 2019 - 2:56 pm
WASHINGTON (AP) — President Donald Trump signed an executive order Wednesday revamping care for kidney disease so more people whose kidneys fail can have a chance at early transplants and home dialysis, and others don't get that sick in the first place. Trump said his order was aimed at "making...
Read More
FILE - In this Sept. 29, 2016 file photo, Spain's singer Julio Iglesias smiles during his star unveiling ceremony at the Walk of Fame in San Juan, Puerto Rico. A Spanish judge has ruled on Wednesday, July 10, 2019 that there exists sufficient evidence to determine that a 43-year-old Spanish man is the biological son of Julio Iglesias, despite the singer’s refusal to submit to genetic testing. The judge said the famous crooner’s refusal to have a DNA test, along with other evidence, is enough to rule in favor of the paternity suit brought by Javier Sanchez. (AP Photo/Carlos Giusti, File)
July 10, 2019 - 12:29 pm
MADRID (AP) — A judge in Spain has found there is sufficient evidence to establish that a 43-year-old man is the biological son of Julio Iglesias even though the singer refused to have a DNA test. The judge, in fact, cited Iglesias' refusal to submit to genetic testing as part of the evidence that...
Read More
FILE - In this Oct. 25, 2018, file photo, President Donald Trump talks about drug prices during a visit to the Department of Health and Human Services in Washington. A federal judge Monday, July 8, 2019, blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads. (AP Photo/Susan Walsh, File)
July 08, 2019 - 10:51 pm
WASHINGTON (AP) — A federal judge Monday blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads. The narrow ruling by U.S. District Judge Amit Mehta in Washington, D.C.,...
Read More

Pages